Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact With Orano

Sanofi’s equity investment in the new Orano Med entity comes a month after the pharmaceutical giant struck a €100 million deal to license a clinical-stage radiopharmaceutical developed for neuroendocrine tumors. Orano Med develops targeted cancer therapies based on lead-212, an alpha-emitting isotope. The post Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact…

Read More

Medicaid’s Health Equity Problem Starts and Ends with Health-Related Social Needs (HRSNs). Why Are They Being Overlooked?

While federal healthcare programs focus their attention on ensuring healthcare resources exist for communities in need, HRSNs become critical drivers of whether individuals can actually access and benefit from these resources.  The post Medicaid’s Health Equity Problem Starts and Ends with Health-Related Social Needs (HRSNs). Why Are They Being Overlooked? appeared first on MedCity News.

Read More

ISPOR’s 2024 HEOR Awards

Who won the ISPOR’s 2024 HEOR awards? The list is below. Avedis Donabedian Lifetime Achievement Award: C. Daniel Mullins, PhD; Professor of Practice, Sciences, and Health Outcomes Research and Executive Director of The PATIENTS Program; University of Maryland School of Pharmacy; Baltimore, MD, USAMarilyn Dix Smith Leadership Award: Deborah Marshall, PhD; Professor and Svare Chair…

Read More